Ineffective Hemopoiesis in the Myelodysplastic Syndromes (MDS) as Studied by Daily In Situ Observation of Colony-Cluster Formation

Size: px
Start display at page:

Download "Ineffective Hemopoiesis in the Myelodysplastic Syndromes (MDS) as Studied by Daily In Situ Observation of Colony-Cluster Formation"

Transcription

1 Original Paper International Journal of Cell Cloning (1991) Ineffective Hemopoiesis in the yelodysplastic Syndromes (DS) as Studied by Daily In Situ Observation of Colony-Cluster ormation asami Ohmori, Seiichi Ohmori, Yarunori Ueda, Yataro Yoshida, inoru Okuma irst Division, Department of Internal edicine, aculty of edicine, Kyoto University, Kyoto, Japan Key Words. DS * Ineffective granulopoiesis ing cells In situ * Individual proliferat- Abstract. Daily in situ observation of individual proliferating cells was performed to examine ineffective hemopoiesis in vitro. Bone marrow mononuclear cells (BNC) from 24 myelodysplastic syndrome (DS) patients and 12 controls were cultured for granuloqte-macrophage progenitor (CU-gm) assays using methylcellulose. Individual proliferating cells were mapped at 3 days of culturing and their fates were followed by daily in situ cell counting contained within each cell aggregate until day 8. By retr~spedve analysis of the daily growth of the cells, a significantly greater proportion of noncolony-forming cells in DS were found to proliferate initially, but failed to do so thereafter and degenerated in the culture. Cells showing these abnormal growth characteristics apparently contributed to ineffective granulopoiesis. The present method may be useful for clarifying ineffective granulopoiesis. Introduction The myelodysplastic syndromes (DS) are characterized by varying degrees of peripheral cytopenias despite cellular bone marrow, and by the presence of abnormal clones [I, 21. In vitro marrow cell cultures in DS revealed defective colony formation and increased cluster formation [l-31. These observations are generally assumed to correspond to ineffective hemopoiesis. However, the precise mechanisms leading to these culture abnormalities remain poorly understood. To gain insight into the mechanisms involved in ineffective hemopoiesis in DS, we have developed a new method of serial in situ observation of individual Correspondence: asami Ohmori,.D., irst Division, Department of Internal edicine, aculty of edicine, Kyoto University, Sakyo-ku, Kyoto 66, Japan. Received January 31, 1991; pmisionally accepted ay 3, 1991; accepted for publication June, /91/$2. Alphaed Press

2 Ineffective Hemopoiesis in DS 22 Table I. Patients characteristics Peripheral blood Case ABa Age Sex no. Hb (gldl) PLT (x3/pl) Leukocyte (/pl> b RS RS RS RS EB EB ANLL ANLL ANLL CoL CoL CoL a AB classification according to the rench-american-british criteria [4]. bcases 13 and, as well as Cases 1, 16 and 19 are the same patients studied serially after progression to overt leukemia. proliferating cells. This method involved mapping of individual cell aggregates after 3 days of methylcellulose culture. The subsequent fate of individual proliferating cells was followed up by daily in situ observation until day 8. The results showed that cellular disintegration, eventually leading to a decrease in the number of viable cells within each aggregate, was a conspicuous feature in DS. aterials and ethods Patients Twenty-four consecutive patients with DS were studied. They were diagnosed ac-

3 Ohmori/Ohmori/Ueda/Yoshida/Okuma 23 cording to the rench-american-british (AB) criteria [4] as having refractory anemia (), refractory anemia with ringed sideroblasts (URS), refractory anemia with excess of blasts (EB), EB in transformation (EB-t), and chronic myelomonocytic leukemia (CoL)(Table I). Two cases of EB-t were examined serially after their diseases progressed to acute nonlymphocytic leukemia (ANLL). Control bone marrow was obtained from I2 healthy volunteers. Cell prepamtions Bone marrow was taken after obtaining informed consent. Lightdensity mononuclear cells were separated by icoll-paque (Pharmacia ine Chemicals, Piscataway, NJ) density gradient centrifugation at 4 g for 3 min, washed three times and resuspended in Iscove s modified Dulbecco s medium WD; GIBCO, Grand Island, NY). The cells were further separated into nonadherent and adherent cells after incubation on plastic tissue culture dishes at 37 C for 6 min in an atmosphere of36 C2. Nonadhemt cells were collected by gentle swirling of the dishes and careful aspiration of the floating cells. Granulocyte-acrophage Colony-onning Units (CU-gm) CU-gm cultures were carried out according to the method originally described by Iscove []. Briefly, 1 X lo nonadherent BNC were incubated in 1 ml ID containing.87% methylcellulose, 2% fetal calf serum (CS; kine Scientific, Santa h a, CA) and ng/d recombinant human granulocyte-macrophage colony-stimulating factor (rhg-cs) (Sumitomo Chemicals, Tokyo). This concentration is optimal for forming CU-gm colonies in our laboratory. or mapping of cell proliferation, a 22 mm2 cover glass marked with an 8 mm2 line grid was attached to the bottom of a 3 rnm plastic culture dish (iles Scientific, Naperville, IL) using transparent taping. Individual proliferating cells were located on the grid on day 3 and were examined daily until day 8 by counting the number of viable cells within each cell aggregate under an inverted microscope. Aggregates of more than 4 cells were scored as colonies on day 8, and aggregates of less than 4 cells were scored as clusters on day 8. Statistical analysis was performed using the Wilcoxon test. Cell Viabilify In some experiments, parallel series of cultures were set up with the same conditions as above and were used to examine the viability of cells contained in each cell aggregate. Specifically, cell aggregates at a given day of culture were carefully aspirated using a thin Pasteur pipette and examined for cell viability by the trypan blue dye exclusion method. Results Individual proliferating cells were mapped on day 3 in the whole culture plates from normal and DS bone marrow samples and their subsequent fates were followed by daily in situ cell countings within each cell aggregate. On the basis of daily in situ counting of viable cells, 3 patterns of cell prolikration were arbitrarily defmed: type. A: continuous growth, in which the number of viable cells increased from day 3 through day 8, leading to the formation of a CU-gm colony or a cluster. On day 8, 88% of the proliferating cells of type A formed a colony, while the remaining 12% of the type A cells formed a cluster (aggregates of less than 4 cells). The degenerated cells were <3% of one colony or cluster (ig. L4 and B).

4 Ineffective Hemopoiesis in DS 24 ig. 1. Growth of CU-gm in A) normal marrow and B) marrow from a case of DS (case ). Cells grew continuously and formed a colony. The photomicrographs show the same cell aggregates taken on day 3 through 8.

5 Ohmori/Ohmori/UeddYoshida/Okuma 2 ig. 2. Growth of noncolony-forming cells in DS marrow (Case 12). Cells initially grew but degenerated by day 6 to 8, eventually leading to a reduction in viable cell counts at day 8. The degenerated cells were 23% of per cell aggregates. The photomicrographs show the same cell aggregates taken on day 3 through 8. Type B: the initial growth was followed by disintegration leading to a reduction in viable cell counts. Approximately % of the cells showing type B formed a colony, since aggregates of more than 4 viable cells on day 8 even in the presence of cell degeneration were scored as a colony. The degenerated cells were 23% of one colony (ig. 2). 'Qpe C: the initial growth was followed by cessation of growth without an apparent reduction in viable cell counts. The degenerated cells were c 3% of one colony (ig. 3). The degenerating cells were routinely assessed under an inverted microscope by morphological changes such as cell swelling, irregular disruption of cytoplasmic border and cell lysis (ig. 4A and B). The morphological estimation of cellular degeneration fitted well with the results of trypan blue exclusion. This was also confirmed by the microscopic observation on successive days. Removal of the plates from the incubator for daily observation did not interfere with the growth behavior of cells, since the numbers of day 8 colony and cluster were comparable to those of parallel cultures that had been kept in the incubator. The cells that formed G colonies by day 8 showed type A not only in normal marrow, but also in DS marrow. The cells continued to proliferate in the culture with less than 3% of degeneration. In type B, most of the aggregates contained cells showing signs of disintegration, such as cellular swelling, distortion of the cytoplasmic border and cell

6 Ineffective Hemopoiesis in DS 26 'ig. 3. Growth of noncolony-forming cells in normal maficrw. Cells initially grew but subsequently ceased to grow without an apparent reduction in viable cell counts. The degenerated cells were <3% of per cell aggregates. The photomicrographs show the same cell aggregates taken on day 3 through 8. lysis. Such signs of degeneration were not observed at day 3, when most cells appeared viable, but became evident with time in culture. The degenerative changes yielded a decrease in the number of viable cells contained within single aggregates in DS, but a similar reduction in the number of viable cells was seen in a smaller fraction of noncolony-forming cells in normal marrow. In type C, most of the aggregates contained cells proliferating until days or 6, but failed to do so thereafter. During culture, increasingly more cells ceased to proliferate, retaining the same number of cell aggregates. The majority of these noncolony-forming cells corresponded to cluster-forming cells. Table I1 shows the distribution of the three growth patterns in the DS and control marrow. Unlike the control marrow, most proliferating cells from DS marrow were of pattern B, and the difference in the mean proportion of proliferating cells showing pattern B between the control (median [9% interval], [O-171) and DS marrow (6 [4-9.81) was statistically significant (p <.1). Although most of the noncolony-forming cells exhibited pattern B or C in both the control and DS marrow, there were significantly fewer proliferating cells showing pattern C in DS ( [O-31) than in the control marrow (3 [6.-1, p <.1). Three cases of untreated aplastic anemia were also examined. CU-gm and non-

7

8 Ineffective Hemopoiesis in DS 28 Wle II. Distribution of colony cluster-forming cells in DS and control marrow according to growth patterns DS CU-p % % % (Case no.) Colony IclusteP Ab Bb Cb f f 7 OfOl Of 7f31 16k7 Of1 Of f 31 2 f 1 OfO/ 2f2 2f21 9f9 f 1 7 f 3 1 * f 1 f f 4 Of1 2f2 4f1124f3 1 f f 28 Of1 Of Of1 2f2 OfOl Of 7f21 16f2 Of1 7f Of1 Of Of1 Of 3f2138f1 1f12f3 OfOl 6f2 24 f f 2 ean f SD 3.8 f f edian (W% interval) Controls (n = 12) 69.2 f f 31.2 Number of colonieslclusters per 1 X los BNC on day 8. (ean f SD of triplicate cultures.) These numbers of colonylcluster were counted on day 8 by parallel standard culture used with same patients BNCs. b attern A = continuous growth; pattern B = initial growth followed by disintegration; pattern C = initial growth followed by cessation of growth. ccontrols included 12 healthy volunteers. cultures suggested either a reduction in the number of progenitors or defects in their capacity to proliferate and differentiate to give rise to colonies. The former possibility is unlikely since cellular marrow can hardly be explained solely by a lack of progenitors.

9 Ohmori/hmori/UedalYoshida/Okuma 29 The present study demonstrated that colony-forming cells, albeit small in number in DS, grew in cultures into CU-gm colonies, as did the control CU-gm (ig. IA and B). However, 6 - % of noncolony-forming cells exhibited initial proliferation, followed by degeneration (ig. 2). These degenerative changes resulted in the reduction of the number of viable cells within single cell aggregates. This growth pattern was also found in a small proportion of the control marrow ( [O-171). However, the difference in the proportion of cells showing pattern B was significantly high in DS (p <.1) (Table IT). This indicates that they are the cells largely responsible for ineffective granulopoiesis in DS. Cells showing similarly impaired growth were also seen in the late erythroid progenitor culture in DS (data not shown). It should be added that all aggregates consisting of more than four cells were mapped and counted after three days of culture. Some might well be immature cells located close together that had divided at least once. However, the majority were clones that arose from single progenitors. Although our primary objective was to study the progenitor cell growth in DS versus control marrows, the present method enabled us to examine the growth patterns of the immature proliferating myeloid cells as well. Our observation revealed that type B growth with degeneration and cell death was also characteristically seen for immature myeloid cells in DS, whereas such cells in control marrows showed exclusively C pattern. It thus appears that abortive growth with degeneration is a striking feature not only of progenitor cells but also of immature dividing myeloid cells in DS. There are several possibilities concerning the mechanisms resulting in growth pattern B. irst, DS progenitors have been reported to respond to higher concentrations of G-CS [9]. The use of increased concentrations of G-CS or other sources of CS, such as human placental-conditioned medium, yielded essentially the same results in growth behavior in our hands (data not shown). Thus, the present results could not be attributed to theconcentrations or sources of CS. Second, DS progenitors may have inherent defects in their potential to proliferate. A third possibility is related to the growth inhibition by leukocytes [-l2] or by marrow macrophages in DS [13]. In a separate study, we have shown the presence of a group of marrow macrophages in DS that have inhibitory activity on CU-gm growth [B]. The inhibition seems to be mediated by soluble factors released by macrophages. The identity of these soluble hctors and their relationship to similar substances [-l2] is currently being examined. The precise relationship between the inhibitory macrophages and ineffective hemopoiesis is under investigation. It also remains to be seen whether growth patterns A and B are the property of the clones of the same origin. In conclusion, daily in situ observation of mapped methylcellulose cultures may provide a useful model for the study of ineffective granulopoiesis.

10 Ineffective Hemopoiesis in DS 3 Acknowledgments This work was supported in part by Grants in Aid for Scientific Research (62742, ) from the inistry of Educaton, Grantskr Intractable Diseases from the inistry of Health and Welfare of Japan. We thank Dr. S. Oguma for statistical analysis, s. C. Yoshida and H. Kitagaw for their valuable assistance References Yoshida Y. Biology of myelodysplastic syndrome. Int J Cell Cloning 1987,: Jacobs A. yelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Path1 l98;38: Senn JS, Pinkerton PH. Defective in vitro colony formation by human bone marrow preceding overt leukaemia. Br J Haematoi 1972;23: Bennett J, Catovsky D, Daniel T, et al. The rench-american-british PAB) co-operative group. Br J Haematol l982;1: Iscove NN, Senn JS, Till JE, cculloch EA. Colony formation by normal and leukemic human marrow cells in culture: effect of conditioned medium from human leukocyte. B ld 1971;371-. Cazzola, Barosi G, Berzuini C, Dacco, Ester Orlandi, Stefanelli, Ascari E. Quantitative evaluation of erythrocyte activity in dysmyelopoietic syndromes. Br J Haematol 1982;: -62. Ricketts C, Jacobs A, Cavil1 I. errokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell lifespan using 9e. Br J Haematol l97;31:6-7. Yoshida Y, Oguma S, Uchino H, aekawa T. Clinical features and prognosis of re- fractory myelodysplastic anemias: a Japanese cooperative study. Acta Haematol Jpn 198% : Carlo-Stella C, Cazzola, Bergamaschi G, Bernasconi P, Dezza L, Invernizzi R, Pedrazzoli P. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response recombinant human granulocyte-macrophage colonystimulating factor. Leukemia l989;3: Bromeyer HE, Bognacki J, Dorner H, aria de Sousa. Identification of leukemiaassociated inhibitory activity as acidic isoferritins. J Exp ed 1981;33: Cukrova V, Neuwirtova R, Cermak J, alaskowva V, Neuwirt J. Leukocytederived inhibitory activity in patients with myelodysplastic syndrome. Blut 1987, Cukrova V, Neuwirtova R, Cermak J, Neuwirt J. Inhibitor of normal granulopoiesis produced by cells of DS patients. Neoplasm 1989;36: Ohmori, Ohmori S, Ueda Y, 'Ibhyama K, Yoshida Y, Uchino H. yelodysplastic syndrome (DS)-associated inhibitory activity on hemopoietic progenitor cells. Br J Haematol 199;74:

Effect of Interleukin 10 on the Hematopoietic Progenitor Cells from Patients with Aplastic Anemia

Effect of Interleukin 10 on the Hematopoietic Progenitor Cells from Patients with Aplastic Anemia Effect of Interleukin 10 on the Hematopoietic Progenitor Cells from Patients with Aplastic Anemia YOSHINOBU ASANO, SHOICHIRO SHIBATA, SHINJI KOBAYASHI, SEIICHI OKAMURA, YOSHIYUKI NIHO First Department

More information

In Vitro Growth of Erythropoietic Progenitor Cells in Long-%rm Remission of Acute Leukemia

In Vitro Growth of Erythropoietic Progenitor Cells in Long-%rm Remission of Acute Leukemia International Journal of Cell Cloning 4: 186-191 (1986) In Vitro Growth of Erythropoietic Progenitor Cells in Long-%rm Remission of Acute Leukemia C. Peschel, G. Konwalinka, D. Geissler, H. Bmunsteiner

More information

Chemotherapeutic Susceptibility of Human Bone Marrow Progenitor Cells and Human Myelogenous Leukemia Cells (HMO) in Co-Culture: Preliminary Report

Chemotherapeutic Susceptibility of Human Bone Marrow Progenitor Cells and Human Myelogenous Leukemia Cells (HMO) in Co-Culture: Preliminary Report International Journal of Cell Cloning 2: 254-262 (1984) Chemotherapeutic Susceptibility of Human Bone Marrow Progenitor Cells and Human Myelogenous Leukemia Cells (HMO) in Co-Culture: Preliminary Report

More information

Rapid Decline of Clonogenic Hemopoietic Progenitors in Semisolid Cultures of Bone Marrow Samples Derived from Patients with Chronic Myeloid Leukemia

Rapid Decline of Clonogenic Hemopoietic Progenitors in Semisolid Cultures of Bone Marrow Samples Derived from Patients with Chronic Myeloid Leukemia Original Manuscript International Journal of Cell Cloning 7314-321 (1989) Rapid Decline of Clonogenic Hemopoietic Progenitors in Semisolid Cultures of Bone Marrow Samples Derived from Patients with Chronic

More information

THE INFLUENCE OF SODIUM FLUORIDE ON THE CLONOGENECITY OF HUMAN HEMATOPOIETIC PROGENITOR CELLS: PRELIMINARY REPORT

THE INFLUENCE OF SODIUM FLUORIDE ON THE CLONOGENECITY OF HUMAN HEMATOPOIETIC PROGENITOR CELLS: PRELIMINARY REPORT 168 Fluoride Vol. 33 No. 4 168-173 2 Research Report THE INFLUENCE OF SODIUM FLUORIDE ON THE CLONOGENECITY OF HUMAN HEMATOPOIETIC PROGENITOR CELLS: PRELIMINARY REPORT Boguslaw Machaliński, a Maria Zejmo,

More information

Juvenile Myelomonocytic Leukemia (JMML)

Juvenile Myelomonocytic Leukemia (JMML) Juvenile Myelomonocytic Leukemia (JMML) JMML: Definition Monoclonal hematopoietic disorder of childhood characterized by proliferation of the granulocytic and monocytic lineages Erythroid and megakaryocytic

More information

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,

More information

Sideroblastic colonies in erythroid cultures grown

Sideroblastic colonies in erythroid cultures grown J Clin Pathol 1985;38:68-72 Sideroblastic colonies in erythroid cultures grown from normal human marrow S KAABA, A JACOBS, K BARNES From the Department ofhaematology, University of Wales College of Medicine,

More information

Effects of Prostaglandin E on the Proliferation and Differentiation of Leukemic Progenitor Cells in Acute Nodymphocytic Leukemia

Effects of Prostaglandin E on the Proliferation and Differentiation of Leukemic Progenitor Cells in Acute Nodymphocytic Leukemia International Journal of Cell Cloning 1 : 440-450 (1983) Effects of Prostaglandin E on the Proliferation and Differentiation of Leukemic Progenitor Cells in Acute Nodymphocytic Leukemia Keiya Ozawa&.l,

More information

Hematology Unit Lab 2 Review Material

Hematology Unit Lab 2 Review Material Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

Treatment of low risk MDS

Treatment of low risk MDS Treatment of low risk MDS Matteo G Della Porta Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Rozzano Milano, Italy matteo.della_porta@hunimed.eu International Prognostic Scoring

More information

Interleukin-l Production in Patients with Nonlymphocytic Leukemia and Myelodysplastic Syndromes

Interleukin-l Production in Patients with Nonlymphocytic Leukemia and Myelodysplastic Syndromes Interleukin-l Production in Patients with Nonlymphocytic Leukemia and Myelodysplastic Syndromes N. J. Simbirtseva 1 A common feature of all cases of myeloid leukemia is a block in normal maturation of

More information

HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN

HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN Anatomy of Bone Marrow Syaffiq Othman Bone Marrow Bone marrow is a

More information

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload Int J Hematol (2008) 88:24 29 DOI 10.1007/s12185-008-0118-z PROGRESS IN HEMATOLOGY Transfusional iron overload and iron chelation therapy Overview of guidelines on iron chelation therapy in patients with

More information

INTRODUCTION TO CYTOGENETICS AND MOLECULAR TESTING IN MDS

INTRODUCTION TO CYTOGENETICS AND MOLECULAR TESTING IN MDS INTRODUCTION TO CYTOGENETICS AND MOLECULAR TESTING IN MDS Saturday, September 29, 2018 Cyrus C. Hsia, HBSc, MD, FRCPC Associate Professor of Medicine, Schulich School of Medicine and Dentistry, Western

More information

Aplastic anemia. Case report. Effect of antithymocyte globulin on erythroid colony formation

Aplastic anemia. Case report. Effect of antithymocyte globulin on erythroid colony formation Case report Aplastic anemia Effect of antithymocyte globulin on erythroid colony formation Susan A. Rothmann Hamburger, Ph.D. Department of Laboratory Hematology and Blood Banking James H. Finke, Ph.D.

More information

APPEARANCE OF ADHERENT CELLS SUPPRESSIVE TO ERYTHROPOIESIS DURING AN EARLY STAGE OF PLASMODIUM BERGHEI INFECTION IN MICE

APPEARANCE OF ADHERENT CELLS SUPPRESSIVE TO ERYTHROPOIESIS DURING AN EARLY STAGE OF PLASMODIUM BERGHEI INFECTION IN MICE APPEARANCE OF ADHERENT CELLS SUPPRESSIVE TO ERYTHROPOIESIS DURING AN EARLY STAGE OF PLASMODIUM BERGHEI INFECTION IN MICE M Asami, T Abe, M Owhashi and Y Nawa Department of Parasitology, Miyazaki Medical

More information

Feasibility of hyperthermia as a purging modality in autologous bone marrow transplantation Wierenga, Pieter Klaas

Feasibility of hyperthermia as a purging modality in autologous bone marrow transplantation Wierenga, Pieter Klaas University of Groningen Feasibility of hyperthermia as a purging modality in autologous bone marrow transplantation Wierenga, Pieter Klaas IMPORTANT NOTE: You are advised to consult the publisher's version

More information

Index. endocytosis, 92 fat cells, 99 myelofibrosis, 390 nerves, 99, 100 sinuses, 90 Bone marrow fatty involution, red and yellow marrow,

Index. endocytosis, 92 fat cells, 99 myelofibrosis, 390 nerves, 99, 100 sinuses, 90 Bone marrow fatty involution, red and yellow marrow, A Adherent layer cell types, 256 adipocytes, 261 endothelial cells, 259-261 function, 262, 263 interactions, 261, 262 macrophage and epitheloid cell, 256-259 Association of hematopoiesis and bone formation,209,210

More information

WHO Update to Myeloproliferative Neoplasms

WHO Update to Myeloproliferative Neoplasms WHO Update to Myeloproliferative Neoplasms Archana M Agarwal, MD, Associate Professor of Pathology University of Utah Department of Pathology/ARUP Laboratories Myeloproliferative Neoplasms The categories

More information

Changes to the 2016 WHO Classification for the Diagnosis of MDS

Changes to the 2016 WHO Classification for the Diagnosis of MDS Changes to the 2016 WHO Classification for the Diagnosis of MDS Welcome to Managing MDS. I am Dr. Ulrich Germing, and today, I will provide highlights from the 14th International Symposium on MDS in Valencia,

More information

DISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS

DISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS DISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS James Clinton, Ph.D. Scientist, ATCC February 19, 2015 About ATCC Founded in 1925, ATCC is a non-profit

More information

Continuous Cell Culture From a Patient With Chronic Myelogenous Leukemia. I. Propagation and Presence of Philadelphia Chromosome 1

Continuous Cell Culture From a Patient With Chronic Myelogenous Leukemia. I. Propagation and Presence of Philadelphia Chromosome 1 Continuous Cell Culture From a Patient With Chronic Myelogenous Leukemia. I. Propagation and Presence of Philadelphia Chromosome 1 LINDA S. LUCAS,2 JACQUELINE J. K..WHANG,3 J. H. TJIO,4 ROBERT A. MANAKER,2

More information

Heme 9 Myeloid neoplasms

Heme 9 Myeloid neoplasms Heme 9 Myeloid neoplasms The minimum number of blasts to diagnose acute myeloid leukemia is 5% 10% 20% 50% 80% AML with the best prognosis is AML with recurrent cytogenetic abnormality AML with myelodysplasia

More information

Supplemental Experimental Procedures

Supplemental Experimental Procedures Cell Stem Cell, Volume 2 Supplemental Data A Temporal Switch from Notch to Wnt Signaling in Muscle Stem Cells Is Necessary for Normal Adult Myogenesis Andrew S. Brack, Irina M. Conboy, Michael J. Conboy,

More information

Generation of monocytederived Dendritic Cells (modcs)

Generation of monocytederived Dendritic Cells (modcs) monocytederived Dendritic (modcs) Application Note Background Dendritic (DCs) are so called because of their characteristic cell surface projections that resemble the dendrites of neurons (see Fig 1 and

More information

myelodysplastic syndrome MDS MDS MDS

myelodysplastic syndrome MDS MDS MDS myelodysplastic syndrome MDS MDS 15 10 3 2004 15 MDS 400 2 65 61 70 MDS MDS 1 1 2 3 3 4 1 4 2 3 4 MDS 1982 Bennett French- American-BritishFAB 1 2 WHO 1999 3 2001 4 2002 Vardiman MDS 5 2WHO FAB refractory

More information

Morfologia normale e patologica

Morfologia normale e patologica Morfologia normale e patologica Gina Zini Centro di Ricerca ReCAMH Dpt. Ematologia Università Cattolica S. Cuore - Roma EMATOLOGIA DI LABORATORIO: percorsi diagnostici e obiettivi clinici. Milano 11-12

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Leukine Page: 1 of 6 Last Review Date: November 30, 2018 Leukine Description Leukine (sargramostim)

More information

Myelodysplastic scoring system with flow cytometry. G Detry B Husson

Myelodysplastic scoring system with flow cytometry. G Detry B Husson Myelodysplastic scoring system with flow cytometry G Detry B Husson Myelodysplastic syndroms Clonal haematopoietic stem cell disease characterized by dysplasia in one or more of the myeloid cell lines

More information

Atomic Bomb and Leukemia ICHIMARU M., TOMONAGA M., AMENOMORI T. AND MATSUO T.

Atomic Bomb and Leukemia ICHIMARU M., TOMONAGA M., AMENOMORI T. AND MATSUO T. Atomic Bomb and Leukemia ICHIMARU M., TOMONAGA M., AMENOMORI T. AND MATSUO T. Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine, Nagasaki, Japan (Received December

More information

Guidelines for diagnosis and management of Adult Myelodysplastic Syndromes (MDS)

Guidelines for diagnosis and management of Adult Myelodysplastic Syndromes (MDS) Guidelines for diagnosis and management of Adult Myelodysplastic Syndromes (MDS) Author: Dr A Pillai, Consultant Haematologist On behalf of the Haematology CNG Re- Written: February 2011, Version 2 Revised:

More information

Novità nelle MDS. Matteo G Della Porta. Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Rozzano Milano, Italy

Novità nelle MDS. Matteo G Della Porta. Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Rozzano Milano, Italy Novità nelle MDS Matteo G Della Porta Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Rozzano Milano, Italy matteo.della_porta@hunimed.eu Outline ARCH Predictive value of somatic

More information

SH A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL

SH A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL SH2017-0124 A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL NEGATIVE John R Goodlad 1, Pedro Martin-Cabrera 2, Catherine Cargo 2 1. Department of Pathology, NHS Greater Glasgow & Clyde, QEUH, Glasgow 2. Haematological

More information

MYELODYSPLASTIC SYNDROMES

MYELODYSPLASTIC SYNDROMES MYELODYSPLASTIC SYNDROMES Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra university hospital, Isfahan university of medical sciences Key Features ESSENTIALS OF DIAGNOSIS Cytopenias

More information

Differentiation Ability of Peripheral Blood Cells from Patients with Acute Leukemia or Blast Crisis in Chronic Myelocytic Leukemia"

Differentiation Ability of Peripheral Blood Cells from Patients with Acute Leukemia or Blast Crisis in Chronic Myelocytic Leukemia Differentiation Ability of Peripheral Blood Cells from Patients with Acute Leukemia or Blast Crisis in Chronic Myelocytic Leukemia" Hoelzer, D.,l, Harriss, E. B.l, Kurrle, E.l, Schmücker, H.l, Hellriegel,

More information

Role of Free Radical Reactions in Myelodysplastic Syndrome. Hitoshi IMANISHI,1,* Shinichi MISAWA,1 Tatsuro and Tatsuo ABE 2

Role of Free Radical Reactions in Myelodysplastic Syndrome. Hitoshi IMANISHI,1,* Shinichi MISAWA,1 Tatsuro and Tatsuo ABE 2 J. Clin. Biochem. Nutr., 5, 75-79, 1988 Role of Free Radical Reactions in Myelodysplastic Syndrome Hitoshi IMANISHI,1,* Shinichi MISAWA,1 Tatsuro and Tatsuo ABE 2 TAKINO,1 1Third Department of Internal

More information

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

Myeloid neoplasms. Early arrest in the blast cell or immature cell we call it acute leukemia Myoid neoplasm divided in to 3 major categories: Myeloid neoplasms Note: Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories: 1. AML : Acute myeloid leukemia(stem cell with myeloid

More information

Hematopoiesis. BHS Liège 27/1/2012. Dr Sonet Anne UCL Mont-Godinne

Hematopoiesis. BHS Liège 27/1/2012. Dr Sonet Anne UCL Mont-Godinne Hematopoiesis BHS Liège 27/1/2012 Dr Sonet Anne UCL Mont-Godinne Hematopoiesis: definition = all the phenomenons to produce blood cells Leukocytes = White Blood Cells Polynuclear = Granulocytes Platelet

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.08 Subject: Leukine Page: 1 of 5 Last Review Date: September 15, 2017 Leukine Description Leukine

More information

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0.

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0. Cell Identification Mitotic figure 212 99.5 Educational Erythrocyte precursor, abnormal BMD-02 The arrowed cell is a mitotic figure. It was correctly identified by 99.5% of the participants. A cell containing

More information

Primary myelofibrosis

Primary myelofibrosis - It s a bone marrow fibrosis Primary myelofibrosis - It's type of myeloproliferative disease i.e. neoplastic proliferation of mature cell of myloid linage. - Its similar to chronic myloid leukemia (CML).

More information

Burst-Promoting Activity in Anemia and hlycythemia

Burst-Promoting Activity in Anemia and hlycythemia International Journal of Cell Cloning 4: 74-81 (1986) Burst-Promoting Activity in Anemia and hlycythemia Hiromi Fukamachi", Akio Urabe", Tsunehiro Saito", Fumimuro Takaku", Mamoru Kubota "The Third Department

More information

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls Myelodysplastic Syndromes: Everyday Challenges and Pitfalls Kathryn Foucar, MD kfoucar@salud.unm.edu Henry Moon lecture May 2007 Outline Definition Conceptual overview; pathophysiologic mechanisms Incidence,

More information

Ultrastructural Study of Human Natural Killer CNK) Cell*)

Ultrastructural Study of Human Natural Killer CNK) Cell*) Hiroshima Journal of Medical Sciences Vol. 31, No. 1, March, 1982 HJIM 31-6 31 Ultrastructural Study of Human Natural Killer CNK) Cell*) Yoshinori KAWAGUCHI, Eishi KITTAKA, Yoshito TANAKA, Takeo TANAKA

More information

EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS

EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS Final report submitted to Virox Technologies, Inc. EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS Syed A. Sattar, M.Sc., Dip. Bact., M.S.,

More information

Effects of Mast Cell Growth Factor on Ara-C Mediated Acute Myeloid Leukemia Cell Killing

Effects of Mast Cell Growth Factor on Ara-C Mediated Acute Myeloid Leukemia Cell Killing Effects of Mast Cell Growth Factor on Ara-C Mediated Acute Myeloid Leukemia Cell Killing A. Tafuri, L. De Felice, M. G. Mascolo, T. Valentini, M. T. Petrucci, M. C. Petti University La Sapienza of Rome,

More information

About Myelodysplastic Syndromes

About Myelodysplastic Syndromes About Myelodysplastic Syndromes Overview and Types If you have been diagnosed with a myelodysplastic syndrome or are worried about it, you likely have a lot of questions. Learning some basics is a good

More information

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009 LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of

More information

SESSION 1 Reactive cytopenia and dysplasia

SESSION 1 Reactive cytopenia and dysplasia SESSION 1 Reactive cytopenia and dysplasia Falko Fend, Tübingen & Alexandar Tzankov, Basel 1 Disclosure of speaker s interests (Potential) conflict of interest none Potentially relevant company relationships

More information

Correspondence should be addressed to Anas Khanfar;

Correspondence should be addressed to Anas Khanfar; Case Reports in Oncological Medicine, Article ID 949515, 4 pages http://dx.doi.org/10.1155/2014/949515 Case Report Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

Analysis of the Viability of Umbilical Cord blood Stem Cells. Sachdeva N

Analysis of the Viability of Umbilical Cord blood Stem Cells. Sachdeva N Jsrm/Vol5No.11, 2009 Original Article Analysis of the of Umbilical Cord blood Stem Cells Sachdeva N Dr. Neelam Sachdeva Reader, Department of Zoology, Gargi College, University of Delhi, Siri Fort Road,

More information

than do normal CFU-C and may suppress proliferation of normal CFU-C in vitro. one X-chromosome, which occurs in each XX somatic

than do normal CFU-C and may suppress proliferation of normal CFU-C in vitro. one X-chromosome, which occurs in each XX somatic Polycythemia Vera INCREASED EXPRESSION OF NORMAL COMMITTED GRANULOCYTIC STEM CELLS IN VITRO AFTER EXPOSURE OF MARROW TO TRITIATED THYMIDINE JACK W. SINGER, PHILIP J. FIALKOW, JOHN W. ADAMSON, LAURA STEINMANN,

More information

News Release. Title Integrated molecular profiling of juvenile myelomonocytic leukemia

News Release. Title Integrated molecular profiling of juvenile myelomonocytic leukemia News Release Title Integrated molecular profiling of juvenile myelomonocytic leukemia Key Points We identified ALK/ROS1 tyrosine kinase fusions (DCTN1-ALK, RANBP2-ALK, and TBL1XR1-ROS1) in patients with

More information

Myelodysplastic Syndromes Myeloproliferative Disorders

Myelodysplastic Syndromes Myeloproliferative Disorders Myelodysplastic Syndromes Myeloproliferative Disorders Myelodysplastic Syndromes characterized by maturation defects that are associated with ineffective hematopoiesis and a high risk of transformation

More information

Inhibition of Mwine CFU-C by Vindesine: Restoration of Colony Growth by Colony Stimulating Factor

Inhibition of Mwine CFU-C by Vindesine: Restoration of Colony Growth by Colony Stimulating Factor International Journal of Cell Cloning 1: 142-150 (1983) Inhibition of Mwine CFU-C by Vindesine: Restoration of Colony Growth by Colony Stimulating Factor Giuseppe Pigoli, Lina Mangoni, Cecilia CaFamatti,

More information

Faculty of Medicine Dr. Tariq Aladily

Faculty of Medicine Dr. Tariq Aladily Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin

More information

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do? 101 May 17, 2014 Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine What is bone marrow? What does bone

More information

Myelodysplastic Syndromes (MDS) Diagnosis, Treatments & Support

Myelodysplastic Syndromes (MDS) Diagnosis, Treatments & Support Myelodysplastic Syndromes (MDS) Diagnosis, Treatments & Support LLS Mission & Goals Our mission. Cure leukemia, lymphoma, Hodgkin s disease and myeloma, and improve the quality of life of patients and

More information

THE ITALIAN EXPERIENCE

THE ITALIAN EXPERIENCE MYELOFIBROSIS THE ITALIAN EXPERIENCE Giovanni Barosi IRCCS Policlinico S. Matteo. Pavia. Italy Angers, 1-3 October 2004 Myelofibrosis in the eighties A poorly characterized biological syndrome Heterogeneity

More information

Cryopreserved HepaRG Cells and Media Supplements

Cryopreserved HepaRG Cells and Media Supplements Cryopreserved HepaRG Cells and Media Supplements Catalog No. MMHPR116 Catalog No. MMADD621 Catalog No. MMADD631 Catalog No. MMADD641 Catalog No. MMADD651 Catalog No. MMADD671 FOR RESEARCH USE ONLY Not

More information

Automated and Standardized Counting of Mouse Bone Marrow CFU Assays

Automated and Standardized Counting of Mouse Bone Marrow CFU Assays Automated and Standardized Counting of Mouse Bone Marrow CFU Assays 2 Automated and Standardized Colony Counting Table of Contents 4 Colony-Forming Unit (CFU) Assays for Mouse Bone Marrow 5 Automated Assay

More information

Hemopoietic Precursors in Human Bone Marrow Transplantation

Hemopoietic Precursors in Human Bone Marrow Transplantation International Journal of Cell Cloning 4: 11-18 Suppl 1 (1986) Hemopoietic Precursors in Human Bone Marrow Transplantation H.A. Messner Ontario Cancer Institute, University of Toronto, Toronto, Ontario,

More information

Case Presentation No. 075

Case Presentation No. 075 Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology

More information

Idiopathic Macrocytosis in Smokers

Idiopathic Macrocytosis in Smokers ORIGINAL ARTICLE Ningen Dock 27 : 689-696, 2012 Idiopathic Macrocytosis in Smokers Masuhiro Takahashi 1), Akie Yamahira 1), Takayoshi Uchiyama 1), Minami Iwabuchi 1), Naoya Sato 1), Jun Takizawa 2), Hirohito

More information

Hemoglobin F synthesis in vitro: Evidence for control

Hemoglobin F synthesis in vitro: Evidence for control Proc. Natl. Acad. Sci. USA Vol. 74, No. 7, pp. 2923-2927, July 1977 Cell Biology Hemoglobin F synthesis in vitro: Evidence for control at the level of primitive erythroid stem cells (Hb F regulation/erythroid

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.10.08 Subject: Leukine Page: 1 of 6 Last Review Date: March 13, 2014 Leukine Description Leukine (sargramostim)

More information

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)

More information

MDS - Diagnosis and Treatments. Dr Helen Enright, Adelaide and Meath Hospital Dr Catherine Flynn, St James Hospital

MDS - Diagnosis and Treatments. Dr Helen Enright, Adelaide and Meath Hospital Dr Catherine Flynn, St James Hospital MDS - Diagnosis and Treatments Dr Helen Enright, Adelaide and Meath Hospital Dr Catherine Flynn, St James Hospital Overview What is myelodysplasia? Symptoms Diagnosis and prognosis Myelodysplasia therapy

More information

Myelodysplastic syndromes in adults aged less than 50 years: Incidence and clinicopathological data

Myelodysplastic syndromes in adults aged less than 50 years: Incidence and clinicopathological data JBUON 2014; 19(4): 999-1005 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Myelodysplastic syndromes in adults aged less than 50 years: Incidence

More information

Myelodysplastic Syndrome Case 158

Myelodysplastic Syndrome Case 158 Myelodysplastic Syndrome Case 158 Dong Chen MD PhD Division of Hematopathology Mayo Clinic Clinical History 86 year old man Persistent borderline anemia and thrombocytopenia. His past medical history was

More information

10.00 PBS OVA OVA+isotype antibody 8.00 OVA+anti-HMGB1. PBS Methatroline (mg/ml)

10.00 PBS OVA OVA+isotype antibody 8.00 OVA+anti-HMGB1. PBS Methatroline (mg/ml) RESEARCH ARTICLE Penh (100% of PBS) 1 PBS 8.00 +anti-hmgb1 6.00 4.00 p=0.054 Cellular & Molecular Immunology advance online publication, PBS 3.12 6.25 Methatroline (mg/ml) Neutrophil isolation and culture

More information

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16 35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will

More information

HL-60 ATP assay for predicting rat oral toxicity study

HL-60 ATP assay for predicting rat oral toxicity study AATEX 14, Special Issue, 699-703 Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan HL-60 ATP assay for predicting rat oral toxicity study Yumiko

More information

Myelodysplastic syndromes

Myelodysplastic syndromes Haematology 601 Myelodysplastic syndromes The myelodysplastic syndromes are a group of disorders predominantly affecting elderly people, leading to ineffective haematopoiesis, and they have the potential

More information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS

More information

Molecular profiling in confirming the diagnosis of early myelodysplastic syndrome

Molecular profiling in confirming the diagnosis of early myelodysplastic syndrome Molecular profiling of early MDS Hematopathology - March 2016 Article Molecular profiling in confirming the diagnosis of early myelodysplastic syndrome Maya Thangavelu 1,*, Ryan Olson 2, Li Li 2, Wanlong

More information

Improved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant

Improved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 2 Copyright 1982, Institute for Clinical Science, Inc. Improved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant ALAN B. LOREN,

More information

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa The Role of the FBC in clinical decision making History Examination Investigations Decision 70% FBC Laboratory

More information

What is MDS? Epidemiology, Diagnosis, Classification & Risk Stratification

What is MDS? Epidemiology, Diagnosis, Classification & Risk Stratification What is MDS? Epidemiology, Diagnosis, Classification & Risk Stratification Rami Komrokji, MD Clinical Director Malignant Hematology Moffitt Cancer Center Normal Blood and Bone Marrow What is MDS Myelodysplastic

More information

Protocol for Thawing Cryopreserved Hepatocytes

Protocol for Thawing Cryopreserved Hepatocytes cell and tissue-based products Protocol for Thawing Cryopreserved Hepatocytes Product Instruction The following procedure may be carried out in a biosafety containment hood to reduce the risk of contamination

More information

Study of diagnostic features of bone marrow in aplastic anaemia

Study of diagnostic features of bone marrow in aplastic anaemia Original article: Study of diagnostic features of bone marrow in aplastic anaemia 1Dr. Poonam Nanwani, 2 Dr. Sativan Khatri* 1MD Pathologist, Assistant Professor, Department of Pathology, M.G.M. Medical

More information

Formation of Blood Cells

Formation of Blood Cells Hematopoiesis Lecture Objectives Name organs responsible for hematopoiesis in the fetus. List the developmental stages of hematopoiesis both prenatally and postnatally. Outline the major steps of post

More information

Case Presentation. Attilio Orazi, MD

Case Presentation. Attilio Orazi, MD Case Presentation Attilio Orazi, MD Weill Cornell Medical College/ NYP Hospital Department of Pathology and Laboratory Medicine New York, NY United States History 60 year old man presented with anemia

More information

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms Daniel A. Arber, MD Stanford University What is an integrated approach? What is an integrated approach? Incorporating all diagnostic

More information

PNH Glossary of Terms

PNH Glossary of Terms AA Absolute neutrophil count Alendronate Allergen ALT Anemia Antibodies Anticoagulant Anticoagulation Antigen Antithymocyte globulin (ATG) Aplastic Aplastic anemia Band Bilirubin Blast cells Bone marrow

More information

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed MYELODYSPLASTIC SYNDROMES: A diagnosis often missed D R. EMMA W YPKEMA C O N S U LTA N T H A E M AT O L O G I S T L A N C E T L A B O R AT O R I E S THE MYELODYSPLASTIC SYNDROMES DEFINITION The Myelodysplastic

More information

Concise Review for Primary-Care Physicians

Concise Review for Primary-Care Physicians Concise Review for Primary-Care Physicians Myelodysplastic (Preleukemia) Syndromes: The Bone Marrow Factory Failure Problem H. CLARK HOAGLAND, M.D. The myelodysplastic syndromes are a group of hematologic

More information

Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma

Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Sex Male Female Intersex/indeterminate Date

More information

Introduction STEM CELLS 1994;12:

Introduction STEM CELLS 1994;12: Growth Factor Stimulation of Cryopreserved CD34 Bone Marrow Cells Intended for Transplant: An In Vitro Study to Determine Optimal Timing of Exposure to Early Acting Cytokines Mariusz Z. Ratajczak, Janina

More information

Further Chromosomal Studies on Irradiated Human

Further Chromosomal Studies on Irradiated Human Jap. Jour. Genet. Vol. 38, No. 2, 106-112 (1963) Further Chromosomal Studies on Irradiated Human Leukocytes in vitrol) Akio AWA, Yasushi OHNUKI, and C. M. POMERAT Zoological Institute, Hokkaido University,

More information

Drug Discoveries & Therapeutics. 2016; 10(3): Cytokine expression profiles in the sera of cutaneous squamous cell carcinoma patients

Drug Discoveries & Therapeutics. 2016; 10(3): Cytokine expression profiles in the sera of cutaneous squamous cell carcinoma patients 172 Brief Report DO: 10.5582/ddt.2016.01032 Cytokine expression profiles in the sera of cutaneous squamous cell carcinoma patients Saori Yamada, asatoshi Jinnin*, kkou Kajihara, Taiji Nakashima, Jun Aoi,

More information

Border between aplastic anemia and myelodysplastic syndrome

Border between aplastic anemia and myelodysplastic syndrome Int J Hematol (2013) 97:558 563 DOI 10.1007/s12185-013-1324-x PROGRESS IN HEMATOLOGY Advances in the management of acquired aplastic anemia (AA) Border between aplastic anemia and myelodysplastic syndrome

More information

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT HPWET Hematopathology Consultation, MML Embed Client Hematopathology Consult REVISED INAL DIAGNOSIS Interpretation Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular

More information

Improvement of Human Melanoma Colony Formation in Soft Agar Using Boiled Instead of Autoclaved Agar

Improvement of Human Melanoma Colony Formation in Soft Agar Using Boiled Instead of Autoclaved Agar International Journal of Cell Cloning 1: 8591 (1983) Improvement of Human Melanoma Colony Formation in Soft Agar Using Boiled Instead of Autoclaved Agar Stephen P. Thomson, Mark D. Wright, Frank L. Meyskens,

More information

Chapter 10 Bone Marrow

Chapter 10 Bone Marrow Chapter 10 Bone Marrow Contents Red Bone Marrow... 188 Hemopoiesis... 189 Early Steps in Hemopoiesis... 190 Late Steps in Hemopoiesis... 190 Yellow Bone Marrow... 197 Guide to Practical Histology: Bone

More information

Blood & Blood Formation

Blood & Blood Formation Module IB Blood & Blood Formation Histology and Embryology Martin Špaček, MD (m.spacek@centrum.cz) http://www.lf3.cuni.cz/histologie Approximately 7% of a person's weight is blood (about 5 L) Blood consists

More information

LCD for Sargramostim (GM-CSF, Leukine ) (L29275)

LCD for Sargramostim (GM-CSF, Leukine ) (L29275) LCD for Sargramostim (GM-CSF, Leukine ) (L29275) Contractor Information Contractor Name First Coast Service Options, Inc. Contractor Number 09102 Contractor Type MAC - Part B LCD ID Number L29275 LCD Information

More information

Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF).

Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF). Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte colony-stimulating factor(g-csf). Granulocyte-macrophage colonystimulating factor (G-CSF). Interleukin-11

More information